Wednesday, December 2, 2020 Daily Archives

Lonza building dedicated conjugation suites for ADC client

by

The two dedicated suites in Visp, Switzerland will support commercialized antibody-drug candidates (ADCs) products for an undisclosed biopharma customer. Contract development and manufacturing organization (CDMO) Lonza has announced 1500 m2 of active manufacturing space will be dedicated to the biopharma customer, in addition to established quality control (QC) labs, logistics and other central services, to Charles Christy, head of Commercial Solutions Ibex Dedicate, Lonza, told us the customer has asked for confidentiality and so details are scarce, but the firm…

December 2, 2020

De-Risking INDs with Unrivaled Monoclonality Assurance in Cell Line Development

by

This webcast features: Tanner Nevill, Vice President, Program Management, Berkeley Lights Monoclonality assurance is a central regulatory requirement for all cell lines manufacturing biologic therapies. Imaging is currently the gold standard for confirming that production cell lines originate from a single cell. However, conventional well plate imaging is very labor-intensive and prone to error due to the presence of “ghost” cells and debris that are difficult to differentiate from cells. Opto™ cell line development (CLD) on the Berkeley Lights Beacon® system provides…

December 2, 2020

Germany’s Merck teams with Siemens to ‘digitalize’ production

by

Merck KGaA will construct a €10 million ($12 million) modular plant at its site in Darmstadt, Germany as part of a collaboration with Siemens for the digitalization of production. The partnership aims to advance the development of a process control system for the manufacture of Merck’s products – including biopharmaceuticals and life science tools – by using Siemens’ tech platforms for the joint development of an overall system for automating the modular production. “We are able to setup any kind…

December 2, 2020